NIH Guide: Weekly Index for September 26, 2025

Funding Opportunities

• NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
  (PAR-25-447)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)
  (PAR-25-449)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
  (PAR-25-450)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
  (RFA-AI-25-012)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): November 07, 2025
• Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
  (RFA-DA-26-020)
  National Institute on Drug Abuse
  Application Receipt Date(s): January 28, 2026
• Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)
  (RFA-HD-26-001)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 20, 2025
• Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed)
  (RFA-RM-25-006)
  National Institutes of Health
  Application Receipt Date(s): November 24, 2025